Publicaciones en colaboración con investigadores/as de New York University School of Medicine (22)

2024

  1. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

    Journal of Extracellular Vesicles, Vol. 13, Núm. 2

2023

  1. Combining Asian and European genome-wide association studies of colorectal cancer improves risk prediction across racial and ethnic populations

    Nature Communications, Vol. 14, Núm. 1

  2. The Dubai Definition and Diagnostic Criteria of Laryngopharyngeal Reflux: The IFOS Consensus

    Laryngoscope

2022

  1. In utero exposure to bisphenols and asthma, wheeze, and lung function in school-age children: a prospective meta-analysis of 8 European birth cohorts

    Environment International, Vol. 162

2021

  1. Genetic architectures of proximal and distal colorectal cancer are partly distinct

    Gut, Vol. 70, Núm. 7, pp. 1325-1334

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2020

  1. Genome-wide association study data reveal genetic susceptibility to chronic inflammatory intestinal diseases and pancreatic ductal adenocarcinoma risk

    Cancer Research, Vol. 80, Núm. 18, pp. 4004-4013

  2. Ovarian cancer risk factor associations by primary anatomic site: The ovarian cancer cohort consortium

    Cancer Epidemiology Biomarkers and Prevention, Vol. 29, Núm. 10, pp. 2010-2018

  3. The risk of ovarian cancer increases with an increase in the lifetime number of ovulatory cycles: An analysis from the Ovarian Cancer Cohort Consortium (OC3)

    Cancer Research, Vol. 80, Núm. 5, pp. 1210-1218

2018

  1. Inhibiting Inflammation with Myeloid Cell-Specific Nanobiologics Promotes Organ Transplant Acceptance

    Immunity, Vol. 49, Núm. 5, pp. 819-828.e6

  2. Targeting the anion exchanger 2 with specific peptides as a new therapeutic approach in b lymphoid neoplasms

    Haematologica, Vol. 103, Núm. 6, pp. 1065-1072

2017

  1. Biomarkers of folate and vitamin B12 and breast cancer risk: report from the EPIC cohort

    International Journal of Cancer, Vol. 140, Núm. 6, pp. 1246-1259

  2. Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition

    Oncogene, Vol. 36, Núm. 19, pp. 2737-2749

2016

  1. Immune cell screening of a nanoparticle library improves atherosclerosis therapy

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 113, Núm. 44, pp. E6731-E6740

2015

  1. Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects

    Brain, Vol. 138, Núm. 9, pp. 2701-2715

  2. Inhibiting macrophage proliferation suppresses atherosclerotic plaque inflammation

    Science Advances, Vol. 1, Núm. 3

  3. Pre-diagnostic polyphenol intake and breast cancer survival: the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort

    Breast Cancer Research and Treatment, Vol. 154, Núm. 2, pp. 389-401

2014

  1. Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33

    Human Molecular Genetics, Vol. 23, Núm. 24, pp. 6616-6633

2011

  1. Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer

    PLoS Biology, Vol. 9, Núm. 11

2010

  1. A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among Caucasians

    Human Molecular Genetics, Vol. 19, Núm. 15, pp. 3089-3101